BANK OF AMERICA CORP /DE/

Bank

Position in PVLA — Palvella Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC

Position in PVLA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,336,941

+$3,603,733 QoQ

Shares Held

54,554

+43.7% QoQ

Ownership

0.379%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 197 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 67% Shared 0% None 33%

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PVLA ranks #123 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,039,178	$1,509,650,884
2	REGN	Regeneron Pharmaceuticals, Inc.	1,291,053	$805,023,185
3	CYTK	Cytokinetics Inc	4,635,709	$394,916,048
4	ARGX	Argenx SE	400,234	$371,325,094
5	ALNY	Alnylam Pharmaceuticals, Inc.	994,476	$299,367,107
6	JAZZ	Jazz Pharmaceuticals plc	1,136,091	$273,763,844
7	TVTX	Travere Therapeutics, Inc.	4,568,341	$259,527,450
8	RPRX	Royalty Pharma plc	4,149,422	$232,658,090

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,336,941	54,554	+43.7%	Shares	Defined	2026-08-14
2026-03-31	$4,733,208	37,972	+25.4%	Shares	Defined	2026-05-18
2025-12-31	$3,168,568	30,272	+545.6%	Shares	Defined	2026-02-17
2025-09-30	$293,953	4,689	+12.3%	Shares	Defined	2026-02-03
2025-06-30	$94,081	4,174	-45.1%	Shares	Defined	2025-08-14
2025-03-31	$212,975	7,609	+63308.3%	Shares	Defined	2025-05-15
2024-12-31	$144	12	—	Shares	Defined	2025-02-14
2024-09-30 PIRS	—	13	0.0%	Shares	Defined	2024-11-14
2024-06-30 PIRS	—	13	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.